172 related articles for article (PubMed ID: 28116670)
1. An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells.
Guo J; Ma D; Huang R; Ming J; Ye M; Kee K; Xie Z; Na J
Protein Cell; 2017 May; 8(5):379-393. PubMed ID: 28116670
[TBL] [Abstract][Full Text] [Related]
2. Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes.
Blinka S; Reimer MH; Pulakanti K; Rao S
Cell Rep; 2016 Sep; 17(1):19-28. PubMed ID: 27681417
[TBL] [Abstract][Full Text] [Related]
3. Single-step generation of gene knockout-rescue system in pluripotent stem cells by promoter insertion with CRISPR/Cas9.
Matsunaga T; Yamashita JK
Biochem Biophys Res Commun; 2014 Feb; 444(2):158-63. PubMed ID: 24462858
[TBL] [Abstract][Full Text] [Related]
4. A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells.
Hazelbaker DZ; Beccard A; Angelini G; Mazzucato P; Messana A; Lam D; Eggan K; Barrett LE
Sci Rep; 2020 Jan; 10(1):635. PubMed ID: 31959800
[TBL] [Abstract][Full Text] [Related]
5. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
[TBL] [Abstract][Full Text] [Related]
6. RNA-Guided Activation of Pluripotency Genes in Human Fibroblasts.
Xiong K; Zhou Y; Blichfeld KA; Hyttel P; Bolund L; Freude KK; Luo Y
Cell Reprogram; 2017 Jun; 19(3):189-198. PubMed ID: 28557624
[TBL] [Abstract][Full Text] [Related]
7. DPPA5 Supports Pluripotency and Reprogramming by Regulating NANOG Turnover.
Qian X; Kim JK; Tong W; Villa-Diaz LG; Krebsbach PH
Stem Cells; 2016 Mar; 34(3):588-600. PubMed ID: 26661329
[TBL] [Abstract][Full Text] [Related]
8. Inducible CRISPRa screen identifies putative enhancers.
Dai Z; Li R; Hou Y; Li Q; Zhao K; Li T; Li MJ; Wu X
J Genet Genomics; 2021 Oct; 48(10):917-927. PubMed ID: 34531148
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
Xiong K; Zhou Y; Hyttel P; Bolund L; Freude KK; Luo Y
Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
[TBL] [Abstract][Full Text] [Related]
10. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies.
Mair B; Tomic J; Masud SN; Tonge P; Weiss A; Usaj M; Tong AHY; Kwan JJ; Brown KR; Titus E; Atkins M; Chan KSK; Munsie L; Habsid A; Han H; Kennedy M; Cohen B; Keller G; Moffat J
Cell Rep; 2019 Apr; 27(2):599-615.e12. PubMed ID: 30970261
[TBL] [Abstract][Full Text] [Related]
11. The synergistic effect of 5Azadc and TSA on maintenance of pluripotency of chicken ESCs by overexpression of NANOG gene.
Wang X; Wang Y; Zuo Q; Li D; Zhang W; Lian C; Tang B; Xiao T; Wang M; Wang K; Li B; Zhang Y
In Vitro Cell Dev Biol Anim; 2016 Apr; 52(4):488-96. PubMed ID: 26822431
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Irradiation Enhances Gene Targeting in Human Pluripotent Stem Cells.
Hatada S; Subramanian A; Mandefro B; Ren S; Kim HW; Tang J; Funari V; Baloh RH; Sareen D; Arumugaswami V; Svendsen CN
Stem Cells Transl Med; 2015 Sep; 4(9):998-1010. PubMed ID: 26185257
[TBL] [Abstract][Full Text] [Related]
13. Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts.
Garreta E; de Oñate L; Fernández-Santos ME; Oria R; Tarantino C; Climent AM; Marco A; Samitier M; Martínez E; Valls-Margarit M; Matesanz R; Taylor DA; Fernández-Avilés F; Izpisua Belmonte JC; Montserrat N
Biomaterials; 2016 Aug; 98():64-78. PubMed ID: 27179434
[TBL] [Abstract][Full Text] [Related]
14. Combining a tetracycline (Tet)-inducible gRNA system and CRISPRa for titratable and timely controlled enhancement of endogenous SHISA3 activation in human induced pluripotent stem cells (hiPSC).
Priesmeier L; Schoger E; Cyganek L; Cecilia Zelarayán L
Stem Cell Res; 2023 Sep; 71():103163. PubMed ID: 37433260
[TBL] [Abstract][Full Text] [Related]
15. BDE-209 inhibits pluripotent genes expression and induces apoptosis in human embryonic stem cells.
Du L; Sun W; Zhang H; Chen D
J Appl Toxicol; 2016 May; 36(5):659-68. PubMed ID: 26206603
[TBL] [Abstract][Full Text] [Related]
16. Generation of a human extended pluripotent stem cell line (SKLRMe002-A) carrying a doxycycline-inducible Cas9 expression cassette.
He Z; Feng K; Sun H; Yu T; Zhu D; Yang Y
Stem Cell Res; 2022 Jul; 62():102816. PubMed ID: 35617843
[TBL] [Abstract][Full Text] [Related]
17. Pluripotentiality and conditional transgene regulation in human embryonic stem cells expressing insulated tetracycline-ON transactivator.
Vieyra DS; Goodell MA
Stem Cells; 2007 Oct; 25(10):2559-66. PubMed ID: 17628023
[TBL] [Abstract][Full Text] [Related]
18. Drug Inducible CRISPR/Cas Systems.
Zhang J; Chen L; Zhang J; Wang Y
Comput Struct Biotechnol J; 2019; 17():1171-1177. PubMed ID: 31462973
[TBL] [Abstract][Full Text] [Related]
19. An all-in-one, Tet-On 3G inducible PiggyBac system for human pluripotent stem cells and derivatives.
Randolph LN; Bao X; Zhou C; Lian X
Sci Rep; 2017 May; 7(1):1549. PubMed ID: 28484230
[TBL] [Abstract][Full Text] [Related]
20. Enhancing stem cell survival in an ischemic heart by CRISPR-dCas9-based gene regulation.
Pan A; Weintraub NL; Tang Y
Med Hypotheses; 2014 Dec; 83(6):702-5. PubMed ID: 25459138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
